Web22 Oct 2024 · Data from a subgroup analysis of CASSIOPEIA that were presented at the 17th International Myeloma Workshop also showcased an improvement in minimal residual disease (MRD) negativity rates and... Web28 Mar 2024 · The CASSIOPEIA phase 3 study included 1085 NDMM ... with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a ...
A Study to Evaluate Daratumumab in Transplant Eligible …
Web13 Sep 2024 · CASSIOPEIA is a two-part, open-label, randomised, phase 3 trial of patients aged 18–65 years with newly diagnosed multiple myeloma and Eastern Cooperative … Web10 Dec 2024 · For example, the CASSIOPEIA study evaluated daratumumab, bortezomib, thalidomide, and dexamethasone (dara-VTd) vs VTd in newly diagnosed patients … get a ccw permit online
Current Advances in Multiple Myeloma: A Post International Myeloma ...
Web28 Dec 2024 · Moreau P, Attal M, Hulin C, et al. Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study. Lancet. 2024;394(10192):29-38. Web23 Mar 2024 · Multiple myeloma is a hematologic cancer in which clonal plasma-cell proliferation leads to complications and death. 1 Initial treatment for newly diagnosed multiple myeloma depends on whether a ... Web26 Oct 2024 · The open-label, multicenter, two-part CASSIOPEIA study (NCT02541383) was designed to evaluate the safety and effectiveness of adding Darzalex to standard pre-transplant therapy in a group of untreated multiple myeloma patients who were eligible for … christmas homily for kids